Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma.
第一作者:
Oleksandr,Ekshyyan
第一单位:
Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
作者:
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);癌, 鳞状细胞(Carcinoma, Squamous Cell);化学疗法, 辅助(Chemotherapy, Adjuvant);女(雌)性(Female);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans);男(雄)性(Male);中年人(Middle Aged);蛋白激酶抑制剂(Protein Kinase Inhibitors);西罗莫司(Sirolimus);TOR丝氨酸-苏氨酸激酶(TOR Serine-Threonine Kinases)
DOI
10.1002/hed.21374
PMID
20222045
发布时间
2021-12-03
- 浏览24
Head & neck
1619-28页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



